Company Information

Company Profile

Cerecor is an integrated biopharmaceutical company developing innovative therapies at the cutting edge of science. Our pipeline, filled with forward-thinking ideas, propels us forward. We are driven to change the lives of patients with rare orphan diseases in Pediatrics and Neurology.

Latest Presentation

Investor Presentation

View This Presentation
Investor Presentation

Cerecor | AEVI Merger

On December 5, 2019, Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan and rare diseases, as well as neurology announced that it had entered into a definitive merger agreement to acquire Aevi Genomic Medicine (NASDAQ: GNMX) in an all-stock transaction valued at approximately $16.1 million at closing, plus contingent value rights, or CVRs, for up to an additional $6.5 million in subsequent milestone payments on clinical or regulatory successes, or both.

Aevi Genomic Investor Presentation
View This Presentation

Contact Information

Investor Relations
ir@cerecor.com

Company Contact
Cerecor, Inc.
540 Gaither Road
Rockville, MD 20850